심혈관용 디지털 헬스 시장 규모, 점유율, 동향 분석 보고서 : 구성 요소별, 최종 용도별, 지역별, 부문 예측(2025-2030년)

Digital Health For Cardiovascular Market Size, Share & Trends Analysis Report By Component (Hardware, Software, Services), By End Use (Patients, Providers, Payers), By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,605,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 10,051,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,944,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

한글목차

심혈관용 디지털 헬스 시장 성장과 동향

Grand View Research, Inc.의 최신 보고서에 따르면 세계의 심혈관용 디지털 헬스 시장 규모는 2025-2030년에 걸쳐 22.5%의 연평균 복합 성장률(CAGR)을 나타내며, 2030년에는 1,409억 6,000만 달러에 달할 것으로 예측되고 있습니다.

이 시장을 견인하고 있는 것은 심혈관 질환(CVDs)의 유병률 증가, 의료 기술의 급속한 진보, 의료 자금과 지출 증가와 함께, 원격 환자 모니터링 서비스 수요 증가를 뒷받침하고 있습니다. 예를 들어, 2023년 8월 원격 심장 모니터링 플랫폼인 Monitra Healthcare는 50만 달러의 자금을 조달하여 환자와 접촉하는 바이오마커를 통해 혈압, 산소 포화도, 호흡수를 원격으로 모니터링하는 서비스 및 유통 채널을 인도 전역으로 확장하는 것을 목표로 했습니다.

노인 증가와 심혈관 질환의 유병률 증가로 인해 여러 지역에서 원격 의료 서비스에 대한 수요가 증가하고 있습니다. 그리고 부유층도 급속히 증가하고 있습니다. 유엔의 보고서에 따르면, 2022-2050년에 걸쳐, 65세 이상의 인구는 10%에서 16%로 증가할 것으로 예상되고 있습니다.

신흥 국가에서는 E 헬스 도입이 증가 추세에 있으며, 인도, 중국, 브라질, 멕시코 등이 E 헬스 전략을 실시했습니다. 예를 들어, 2023년 11월 인도 케랄라주의 스타트업인 Versicles Technologies는 혈당, 혈압, 심장 상태와 같은 기본적인 진단 케어를 매우 저렴한 가격에 최대한 정확하게 제공하기 위해 개발된 키오스크 앱 'Prognosis'를 출시했습니다.

일부 주요 기업들은 포트폴리오와 제품 라인을 확대하고 시장에서의 지위를 강화하기 위해 소규모로 사업을 펼치고 있는 다른 제조체를 인수하고 있습니다. 예를 들어, 2022년 9월, 최고의 원격 심장 임상 솔루션 및 모니터링을 제공하는 회사인 PrepMD RMS는 지적 재산 및 기술 자산을 인수했다고 발표했습니다. 이 인수는 다양한 심장병 클리닉의 IBHRE 인증 팀이 원격 모니터링 부문에서 원활하게 운영하는 데 도움이 될 것입니다.

게다가, 특히 원격지에서의 전문적인 심장 건강 컨설팅에 대한 수요 증가는 원격 의료 순환기 서비스의 성장을 가속하는 중요한 요인 중 하나입니다. 예를 들어, 2023년 11월 미국심장협회는 원격 의료 서비스 및 원격 의료 커뮤니티 개발을 위해 1,590만 달러의 보조금을 받았습니다. 또 다른 사례로, 2023년 8월에 원격 의료 스타트업인 Ventricle은 800만 달러의 자금을 지원받았습니다.

심혈관용 디지털 헬스 시장 보고서 하이라이트

• 서비스 부문은 2024년에 최대 37.9% 시장 점유율을 차지했습니다.
• 2024년의 수익 점유율은 34.5%로, 환자 부문이 심혈관용 디지털 헬스 산업을 지배했고, 예측 기간에서 가장 빠른 성장이 예측됩니다.
• 북미는 디지털 인프라를 지원하기 위한 의료 IT 지출 증가, 기술 진보의 성장, 정부의 지원 이니셔티브에 의해 2024년에 37.7%의 수익 점유율로 심혈관용 디지털 헬스 산업 전체를 지배했습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 심혈관용 디지털 헬스 시장 변수, 동향, 범위

• 시장 계통의 전망
  • 모 시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 심혈관계를 위한 디지털 헬스 : 시장 분석 도구
  • 산업 분석 - Porter's Five Forces 분석
  • PESTLE 분석
• 규제 상황
• 기술
• 디지털 헬스 : 의료 시스템용 성과와 기회
• 심혈관용 디지털 헬스의 신흥 기업과 기존 기업 분석
• 의료 모바일 앱의 동향
• 심혈관용 디지털 헬스 시장 진출기업 개요
• 심혈관용 디지털 헬스 - 이용 사례
• 디지털 헬스 생태계(환자 중심)
• 디지털 헬스 생태계(기업별)
• 경쟁 랭킹
• 디지털 헬스 투자

제4장 심혈관용 디지털 헬스 시장 : 구성 요소별(2018-2030년)

• 정의와 범위
• 구성 요소 시장 점유율 분석(2024년, 2030년)
• 부문 대시보드
• 세계의 심혈관용 디지털 헬스 시장 : 구성 요소별(2018-2030년)
• 소프트웨어
• 하드웨어
• 서비스

제5장 심혈관용 디지털 헬스 시장 : 최종 용도별(2018-2030년)

• 정의와 범위
• 최종 용도 시장 점유율 분석(2024년, 2030년)
• 부문 대시보드
• 세계의 심혈관용 디지털 헬스 시장 : 최종 용도별(2018-2030년)
• 환자
• 공급업체
• 지불자
• 기타

제6장 심혈관용 디지털 헬스의 분석, 지역별, 구성 요소별, 최종 용도별(2018-2030년)

• 지역별 시장 점유율 분석(2024년, 2030년)
• 지역별 시장 대시보드
• 지역 시장 현황
• 심혈관용 디지털 헬스 시장 점유율(지역별, 2024년, 2030년)
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 스웨덴
  • 덴마크
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 싱가포르
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제7장 경쟁 구도

• 주요 시장 진출기업에 의한 최근의 동향과 영향 분석
• 기업/경쟁의 분류
• 기업 포지션 분석(히트 맵 분석)
• 기업 프로파일
  • Epic Systems Corporation
  • Orange Business
  • Apple, Inc.
  • Siemens Healthineers AG
  • NXGN Management, LLC.
  • GE HealthCare
  • CardiAI
  • Ultromics Limited.
  • Cardiologs
  • Ultrasight
  • HeartVista Inc.(Vista.ai)
  • Viz.ai, Inc.
  • RSIP Vision
  • Cleerly, Inc.

KTH

영문 목차

영문목차

Digital Health For Cardiovascular Market Growth & Trends:

The global digital health for cardiovascular market size is anticipated to reach USD 140.96 billion by 2030, registering a CAGR of 22.5% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by the increasing prevalence of cardiovascular diseases (CVDs), rapid advancements in healthcare technology, along with rising healthcare funding and expenditure boosting the growing demand for remote patient monitoring services; for instance, in August 2023, Monitra Healthcare, a remote heart monitoring platform raised a funding of USD 500K, which further aimed at expanding the services and distribution channel across India for remotely monitoring blood pressure, oxygen saturation, and respiratory rate across biomarkers which were in contact with patients.

There is an increasing demand for telehealth services in several regions due to the growing elderly population and rising prevalence of cardiovascular diseases. According to WHO estimates, the population aged 60 years or over is estimated to reach 2.1 billion by 2050 globally. Moreover, the middle class and affluent population across the globe are also growing rapidly. According to the Unit ed Nations report, it is expected that the population aged 65 and above will rise from 10% to 16% from 2022 to 2050. The increasing healthcare needs and shortage of medical professionals are anticipated to drive the market growth.

E-Health adoption is on the rise in developing nations, with countries like India, China, Brazil, and Mexico implementing eHealth strategies. Government efforts, including awareness programs and healthcare IT research & development funding, are expected to foster mHealth adoption in these regions. For instance, in November 2023, Versicles Technologies, a start-up from Kerala, India, launched its Prognosis app as Kiosk', which is developed to provide basic diagnostics care like blood sugar, blood pressure, and heart conditions at extremely low prices, with utmost accuracy. Moreover, various apps, such as Practo, AssistRx, and Wareed, have emerged globally over the last decade to assist patients in booking appointments, monitoring consultations and prescriptions, and managing their health information throughout treatment.

Several key players are acquiring other manufacturers, operating on a small scale, to extend their portfolio and product lines and strengthen their market positions. For instance, in September 2022, PrepMD RMS, a company providing premier remote cardiac clinical solutions and monitoring, announced the acquisition of Intellectual property and technology assets; this acquisition will help the company for smooth operations in remote monitoring space through its IBHRE-certified team within various cardiology clinics. Such strategic initiatives by the players help bolster market growth.

Furthermore, the growing demand for specialty heart health consulting, especially in remote areas, is one of the significant factors driving the growth of telehealth cardiovascular services. Increasing investments in the telehealth industry is another key factor responsible for the increasing demand in the market. For instance, in November 2023, the American Heart Association received a grant of USD 15.9 million for developing telehealth services and the telehealth community. In another development, in August 2023, telehealth startup Ventricle received USD 8 Million in funding. Furthermore, increasing government initiatives for the development of telehealth programs are expected to propel the growth of these services in the market.

Digital Health For Cardiovascular Market Report Highlights:

• The services segment accounted for the largest market share of 37.9% in 2024. Service providers in the market are offering their solutions both as integrated packages and as individual products.
• The patient segment dominated the digital health for cardiovascular industry with a revenue share of 34.5% in 2024 and is anticipated to witness the fastest growth over the forecast period.
• North America dominated the overall digital health for cardiovascular industry in 2024 with a revenue share of 37.7%, due to the increasing healthcare IT expenditure for supporting digital infrastructure, growing technological advancements, and supportive government initiatives.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Regional scope
  • 1.1.3. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Component outlook
  • 2.2.2. End Use outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Digital Health For Cardiovascular Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Digital Health For Cardiovascular: Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTLE Analysis
• 3.4. Regulatory Landscape
• 3.5. Technology Landscape
• 3.6. Digital Health: Accomplishments and Opportunities Across the Health System Sectors
• 3.7. Analysis on Start-ups and Established Companies in Digital Health For Cardiovascular Market
• 3.8. Healthcare Mobile App Trends
• 3.9. Digital Health For Cardiovascular Market Participants Overview
• 3.10. Digital Health For Cardiovascular Market - Case Study
• 3.11. Digital Health Ecosystem (Patient Centric)
• 3.12. Digital Health Ecosystem (By Companies)
• 3.13. Competitive Ranking
• 3.14. Digital Health Investments

Chapter 4. Digital Health For Cardiovascular Market: Segment Analysis, By Component, 2018 - 2030 (USD Million)

• 4.1. Definition and Scope
• 4.2. Component Market Share Analysis, 2024 & 2030
• 4.3. Segment Dashboard
• 4.4. Global Digital Health For Cardiovascular Market by Component, 2018 to 2030
• 4.5. Software
  • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.6. Hardware
  • 4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.7. Services
  • 4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Digital Health For Cardiovascular Market: Segment Analysis, By End Use, 2018 - 2030 (USD Million)

• 5.1. Definition and Scope
• 5.2. End Use Market Share Analysis, 2024 & 2030
• 5.3. Segment Dashboard
• 5.4. Global Digital Health For Cardiovascular Market by End Use
• 5.5. Patients
  • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 5.6. Providers
  • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 5.7. Payers
  • 5.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 5.8. Others
  • 5.8.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Digital Health For Cardiovascular Segment Analysis, By Region, By Component, By End Use, 2018 - 2030 (USD Million)

• 6.1. Regional Market Share Analysis, 2024 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Regional Market Snapshot
• 6.4. Digital Health For Cardiovascular Market Share by Region, 2024 & 2030 by Region
• 6.5. North America
  • 6.5.1. U.S.
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Regulatory framework/ reimbursement structure
    • 6.5.1.3. Competitive scenario
    • 6.5.1.4. U.S. digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.2. Canada
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework/ reimbursement structure
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. Canada digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.3. Mexico
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework/ reimbursement structure
    • 6.5.3.3. Competitive scenario
    • 6.5.3.4. Mexico digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Europe
  • 6.6.1. UK
    • 6.6.1.1. Key country dynamics
    • 6.6.1.2. Regulatory framework/ reimbursement structure
    • 6.6.1.3. Competitive scenario
    • 6.6.1.4. UK digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.2. Germany
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework/ reimbursement structure
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. Germany digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.3. France
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Regulatory framework/ reimbursement structure
    • 6.6.3.3. Competitive scenario
    • 6.6.3.4. France digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.4. Italy
    • 6.6.4.1. Key country dynamics
    • 6.6.4.2. Regulatory framework/ reimbursement structure
    • 6.6.4.3. Competitive scenario
    • 6.6.4.4. Italy digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.5. Spain
    • 6.6.5.1. Key country dynamics
    • 6.6.5.2. Regulatory framework/ reimbursement structure
    • 6.6.5.3. Competitive scenario
    • 6.6.5.4. Spain digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.6. Norway
    • 6.6.6.1. Key country dynamics
    • 6.6.6.2. Regulatory framework/ reimbursement structure
    • 6.6.6.3. Competitive scenario
    • 6.6.6.4. Norway digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.7. Sweden
    • 6.6.7.1. Key country dynamics
    • 6.6.7.2. Regulatory framework/ reimbursement structure
    • 6.6.7.3. Competitive scenario
    • 6.6.7.4. Sweden digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.8. Denmark
    • 6.6.8.1. Key country dynamics
    • 6.6.8.2. Regulatory framework/ reimbursement structure
    • 6.6.8.3. Competitive scenario
    • 6.6.8.4. Denmark digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Japan
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Regulatory framework/ reimbursement structure
    • 6.7.1.3. Competitive scenario
    • 6.7.1.4. Japan digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.2. China
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework/ reimbursement structure
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. China digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.3. India
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Regulatory framework/ reimbursement structure
    • 6.7.3.3. Competitive scenario
    • 6.7.3.4. India digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.4. Australia
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Regulatory framework/ reimbursement structure
    • 6.7.4.3. Competitive scenario
    • 6.7.4.4. Australia digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.5. South Korea
    • 6.7.5.1. Key country dynamics
    • 6.7.5.2. Regulatory framework/ reimbursement structure
    • 6.7.5.3. Competitive scenario
    • 6.7.5.4. South Korea digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.6. Singapore
    • 6.7.6.1. Key country dynamics
    • 6.7.6.2. Regulatory framework/ reimbursement structure
    • 6.7.6.3. Competitive scenario
    • 6.7.6.4. Singapore digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
• 6.8. Latin America
  • 6.8.1. Brazil
    • 6.8.1.1. Key country dynamics
    • 6.8.1.2. Regulatory framework/ reimbursement structure
    • 6.8.1.3. Competitive scenario
    • 6.8.1.4. Brazil digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8.2. Argentina
    • 6.8.2.1. Key country dynamics
    • 6.8.2.2. Regulatory framework/ reimbursement structure
    • 6.8.2.3. Competitive scenario
    • 6.8.2.4. Argentina digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
• 6.9. MEA
  • 6.9.1. South Africa
    • 6.9.1.1. Key country dynamics
    • 6.9.1.2. Regulatory framework/ reimbursement structure
    • 6.9.1.3. Competitive scenario
    • 6.9.1.4. South Africa digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9.2. Saudi Arabia
    • 6.9.2.1. Key country dynamics
    • 6.9.2.2. Regulatory framework/ reimbursement structure
    • 6.9.2.3. Competitive scenario
    • 6.9.2.4. Saudi Arabia digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9.3. UAE
    • 6.9.3.1. Key country dynamics
    • 6.9.3.2. Regulatory framework/ reimbursement structure
    • 6.9.3.3. Competitive scenario
    • 6.9.3.4. UAE digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9.4. Kuwait
    • 6.9.4.1. Key country dynamics
    • 6.9.4.2. Regulatory framework/ reimbursement structure
    • 6.9.4.3. Competitive scenario
    • 6.9.4.4. Kuwait digital health for cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Company Position Analysis (Heatmap Analysis)
• 7.4. Company Profiles
  • 7.4.1. Epic Systems Corporation
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Product benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. Orange Business
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Product benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. Apple, Inc.
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Product benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. Siemens Healthineers AG
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Product benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. NXGN Management, LLC.
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Product benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. GE HealthCare
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Product benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. CardiAI
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Product benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. Ultromics Limited.
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Product benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. Cardiologs
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Product benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. Ultrasight
    • 7.4.10.1. Company overview
    • 7.4.10.2. Financial performance
    • 7.4.10.3. Product benchmarking
    • 7.4.10.4. Strategic initiatives
  • 7.4.11. HeartVista Inc. (Vista.ai)
    • 7.4.11.1. Company overview
    • 7.4.11.2. Financial performance
    • 7.4.11.3. Product benchmarking
    • 7.4.11.4. Strategic initiatives
  • 7.4.12. Viz.ai, Inc.
    • 7.4.12.1. Company overview
    • 7.4.12.2. Financial performance
    • 7.4.12.3. Product benchmarking
    • 7.4.12.4. Strategic initiatives
  • 7.4.13. RSIP Vision
    • 7.4.13.1. Company overview
    • 7.4.13.2. Financial performance
    • 7.4.13.3. Product benchmarking
    • 7.4.13.4. Strategic initiatives
  • 7.4.14. Cleerly, Inc.
    • 7.4.14.1. Company overview
    • 7.4.14.2. Financial performance
    • 7.4.14.3. Product benchmarking
    • 7.4.14.4. Strategic initiatives

관련자료